- Scholarly Journal
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial
PDF
CiteCite
Copy URL
https://www.proquest.com/scholarly-journals/safety-tolerability-pharmacokinetics/docview/3207385529/se-2?accountid=208611
PrintAll Options